常用中药肝毒性成分代谢与毒理研究进展
|
摘要
近年来,随着我国医药卫生健康产业的稳步发展,中医药逐步获得世界人民的认可和信赖,中药在临床治疗和养生保健方面的使用量逐步攀升,其研究价值也日益凸显。然而,中药在使用过程中伴随的毒副作用也引起广泛的关注,因中药制剂服用不当所导致肝功能损害时有报道。迫切需要深入研究和整理中药肝毒性机制,保障常用中药的临床安全有效。在查阅近几年来常见中药肝毒性相关文献的基础上,从代谢与分子方面深入分析常用中药肝毒性成分的毒理机制,以期为中药肝毒性研究提供新思路,为中药临床合理使用提供有益参考。
In recent years, with the steady development of the medicine and health industry in China, Chinese medicine has gradually been recognised and trusted by people around the world, its application amount has being increased in clinic and health care. The worth of its research is also becoming more and more prominent. However, the toxicity and side effects of Chinese materia medica(CMM) have aroused widespread attention, the increasing number of patients with liver function damage has occurred. Thereby, it is urgent to further analyse and study the mechanism of liver toxicity of CMM to ensure the clinical safety and efficacy of common CMM. Based on the latest literatures about hepatotoxicity of common CMM in recent years, the present study analyzed the major mechanism of hepatotoxicity of CMM from the perspective of metabolism and toxicology, in order to provide a novel approach for hepatotoxicity investigation of CMM, and offer the useful reference for the rational application of CMM in clinic.
In recent years, with the steady development of the medicine and health industry in China, Chinese medicine has gradually been recognised and trusted by people around the world, its application amount has being increased in clinic and health care. The worth of its research is also becoming more and more prominent. However, the toxicity and side effects of Chinese materia medica(CMM) have aroused widespread attention, the increasing number of patients with liver function damage has occurred. Thereby, it is urgent to further analyse and study the mechanism of liver toxicity of CMM to ensure the clinical safety and efficacy of common CMM. Based on the latest literatures about hepatotoxicity of common CMM in recent years, the present study analyzed the major mechanism of hepatotoxicity of CMM from the perspective of metabolism and toxicology, in order to provide a novel approach for hepatotoxicity investigation of CMM, and offer the useful reference for the rational application of CMM in clinic.
引文
[1]Dakhoul L,Ghabril M,Chalasani N.Drug-induced chronic liver injury[J].J Hepatol,2018,doi:10.1016/j.jhep.
[2]Yamashita Y I,Imai K,Mima K,et al.Idiosyncratic drug-induced liver injury:A short review[J].Hepatol Commun,2017,1(6):494-500.
[3]Clark J,Mcgoey L.The black box warning on philanthrocapitalism[J].Lancet,2016,388(10059):2457-2459.
[4]Cosyns B,Droogmans S.‘Black box warning’on food and drug administration criteria for drug-induced heart valve disease?[J].Eur Heart J Cardiov Imag,2015,16(2):154-155.
[5]Zeidan A M,Gore S D,Davidoff A J.US food and drug administration black box warning and its impact on the use of erythropoiesis-stimulating agents:Thinking outside the box[J].J Clin Oncol,2017,35(28):3264.
[6]孙润菲,孙明瑜.中草药诱导肝损伤的研究进展[J].中国医刊,2017,52(3):13-17.
[7]吴豪,钟荣玲,夏智,等.潜在肝毒性中药的成分研究进展[J].中国中药杂志,2016,41(17):3209-3217.
[8]雷怀成,易建华,刘涛.乌头碱中毒肝细胞凋亡的观察[J].毒理学杂志,2004,18(3):199-200.
[9]张开乔,卓荦,刘茜,等.乌头碱中毒的法医学研究进展[A]//证据理论与科学国际研讨会论文集[C].北京:中国政法大学2009.
[10]孙蓉,王晨.北豆根毒性研究进展[J].中国药物警戒,2009,6(9):546-549.
[11]曹思硕,杜军.吴茱萸毒理学研究进展[J].毒理学杂志,2017,31(5):396-400.
[12]张茜,周绮,金若敏,等.吴茱萸次碱对肝肾毒性的初步研究[J].中国实验方剂学杂志,2011,17(8):221-225.
[13]郭秋平,金若敏.苦参碱和氧化苦参碱致小鼠肝毒性比较[J].中国药理学与毒理学杂志,2016,30(7):736-740.
[14]Dreger M,Stanis?awska M,Krajewskapatan A,et al.Pyrrolizidine alkaloids-chemistry,biosynthesis,pathway,toxicity,safety and perspectives of medicinal usage[J].Herba Polonica,2009,55(4):127-147.
[15]Wiedenfeld H.Plants containing pyrrolizidine alkaloids:toxicity and problems[J].Food Add Contam,2011,28(3):282-292.
[16]Edgar J A,Colegate S M,Boppr?M,et al.Pyrrolizidine alkaloids in food:A spectrum of potential health consequences[J].Food Add Contam,2011,28(3):308-324.
[17]Merz K H,Schrenk D.Interim Relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines[J].Toxicol Lett,2016,doi:org/10.1016/j.toxlet.2916.05.002.
[18]Ruan J,Yang M,Fu P,et al.Metabolic activation of pyrrolizidine alkaloids:insights into the structural and enzymatic basis[J].Chem Res Toxicol,2014,27(6):1030-1039.
[19]Chen M,Li L,Zhong D,et al.9-Glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine is the major pyrrolic glutathione conjugate of retronecine-type pyrrolizidine alkaloids in liver microsomes and in rats[J].Chem Res Toxicol,2016,29(2):180-189.
[20]Wang C C,Xia Q,Li M,et al.Metabolic activation of pyrrolizidine alkaloids leading to phototoxicity and photogenotoxicity in human Ha Ca T keratinocytes[J].JEnvir Sci Health Part C Envir Carcinog Ecotoxicol Rev,2014,32(4):362-384.
[21]Merz K H,Schrenk D.Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines[J].Toxicol Lett,2016,263:44-57.
[22]Neuman M G,Cohen L,Opris M,et al.Hepatotoxicity of pyrrolizidine alkaloids[J].J Pharm Pharm Sci,2015,18(4):825-843.
[23]Yan X,Hong K,Feng J,et al.Identification of toxic pyrrolizidine alkaloids and their common hepatotoxicity mechanism[J].Int J Mol Sci,2016,17(3):318.
[24]Yang X,Li W,Sun Y,et al.A Comparative study of hepatotoxicity of pyrrolizidine alkaloids retrorsine and monocrotaline[J].Chem Res Toxicol,2017,30(2):532-539.
[25]Chen T,Mei N,Fu P P.Genotoxicity of pyrrolizidine alkaloids[J].J Appl Toxicol Jat,2010,30(3):183-196.
[26]Xia Q,Ma L,He X,et al.7-Glutathione pyrrole adduct-Apotential DNA reactive metabolite of pyrrolizidine alkaloids[J].Chem Res Toxicol,2015,28(4):615-620.
[27]Xia Q,Zhao Y,Tungeln L S V,et al.Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity[J].Chem Res Toxicol,2013,26(9):1384-1396.
[28]Tu M,Li L,Lei H,et al.Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity[J].Toxicology,2014,322(4):34-42.
[29]Tu M,Sun S,Wang K,et al.Organic cation transporter 1mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity[J].Toxicology,2013,311(3):225-230.
[30]Naumann C,Hartmann T,Ober D.Evolutionary recruitment of a flavin-dependent monooxygenase for the detoxification of host plant-acquired pyrrolizidine alkaloids in the alkaloid-defended arctiid moth Tyria jacobaeae[J].Proceed Nat Acad Sci USA,2002,99(9):6085-6090.
[31]Yang M,Ruan J,Fu P P,et al.Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells:Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity[J].Chemico-Biol Interact,2016,243:119-126.
[32]Gao H,Ruan J Q,Chen J,et al.Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome[J].Drug Design Dev Therapy,2015,9:4861-4868.
[33]Ruan J,Gao H,Li N,et al.Blood pyrrole-protein adducts-A biomarker of pyrrolizidine alkaloid-induced liver injury in humans[J].J Envir Sci Health Part CEnvir Carcinog Ecotoxicol Rev,2015,33(4):404-421.
[34]Gao H,Li N,Wang J Y,et al.Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids[J].J Digestive Diseases,2012,13(1):33-39.
[35]姚军,戚新明,任进.野百合碱毒性机制研究进展[J].毒理学杂志,2014,doi:10.16421/j.cnki.1002-3127.
[36]Edgar J A,Molyneux R J,Colegate S M.Pyrrolizidine alkaloids:Potential role in the etiology of cancers,pulmonary hypertension,congenital anomalies,and liver disease[J].Chem Res Toxicol,2014,28(1):4-20.
[37]Hanumegowda U M,Copple B L,Shibuya M,et al.Basement membrane and matrix metalloproteinases in monocrotaline-induced liver injury[J].Toxicol Sci,2003,76(1):237-246.
[38]Luckert C,Hessel S,Lenze D,et al.Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids:A whole genome transcriptome analysis[J].Toxicology In Vitro,2015,29(7):1669-1682.
[39]Xiong A,Yang F,Fang L,et al.Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine,a hepatotoxic pyrrolizidine alkaloid[J].Chem Res Toxicol,2014,27(8):775-786.
[40]骆永伟,施畅,原野,等.雷公藤甲素的毒理学研究进展[J].毒理学杂志,2009,23(1):74-77.
[41]Liu J,Li L,Zhou X,et al.Metabolite profiling and identification of triptolide in rats[J].J Chromatogr BAnalyt Technol Biomed Life Sci,2013,939(22):51-58.
[42]Peng Z H,Wang J J,Du P,et al.Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography-tandem mass spectrometry[J].J Pharm Biomed Anal,2012,70(11):624-630.
[43]Du F,Liu T,Liu T,et al.Metabolite identification of triptolide by data-dependent accurate mass spectrometric analysis in combination with online hydrogen/deuterium exchange and multiple data-mining techniques[J].Rapid Commun Mass Spectrom,2011,25(20):3167-3177.
[44]Du F,Liu Z,Li X,et al.Metabolic pathways leading to detoxification of triptolide,a major active component of the herbal medicine Tripterygium wilfordii[J].J Appl Toxicol,2014,34(8):878-884.
[45]Zhuang X M,Shen G L,Xiao W B,et al.Assessment of the roles of P-glycoprotein and cytochrome P450 in triptolide-induced liver toxicity in sandwich-cultured rat hepatocyte model[J].Drug Metab Disp,2013,41(12):2158-2165.
[46]Lu Y,Xie T,Zhang Y,et al.Triptolide induces hepatotoxicity via inhibition of CYP450s in rat liver microsomes[J].Bmc Compl Altern Med,2017,17(1):15.
[47]姚金成,饶健,曾令贵,等.雷公藤甲素单次及多次给药对大鼠肝药酶活性的影响[J].中国药房,2010,21(11):961-964.
[48]Shen G,Zhuang X,Xiao W,et al.Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes[J].Food Chem Toxicol,2014,71(8):90-96.
[49]周利婷,曲晓宇,陶娌娜,等.雷公藤甲素致小鼠肝损伤对转运体Mrp2和Oatp2的影响[J].中国医院药学杂志,2016,36(21):1844-1847.
[50]姚金成,刘颖,胡领,等.雷公藤甲素对Caspase诱导人肝细胞L-02凋亡机制的研究[J].中国药房,2012,23(43):4036-4038.
[51]周静,张磊,吴瑕,等.雷公藤甲素对L-O2细胞凋亡及Caspase-3、ATPase、MMP、Ca2+的影响[J].中药药理与临床,2016,32(6):72-75.
[52]姚金成,刘颖,胡领,等.雷公藤甲素对人肝细胞L-02钙离子及P38MAPK磷酸化的影响[J].中国医院药学杂志,2013,33(10):760-763.
[53]刘泽洲,许可嘉,张天娇,等.雷公藤甲素诱导小鼠急性肝损伤的形态学研究[J].现代生物医学进展,2015,15(17):3207-3211.
[54]于淑静,魏彩冰,陶崑,等.雷公藤甲素致小鼠肝损伤的机制研究[J].天然产物研究与开发,2017,29(3):472-476.
[55]Wang X,Jiang Z,Xing M,et al.Interleukin-17 mediates triptolide-induced liver injury in mice[J].Food Chem Toxicol,2014,71(8):33-41.
[56]Wang X,Jiang Z,Cao W,et al.Th17/Treg imbalance in triptolide-induced liver injury[J].Fitoterapia,2014,93(3):245-251.
[57]Jing J,Xiaozhe S,Zhongxiang Z,et al.Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity[J].Phytomed Int J Phytotherapy Phytopharmacol,2015,22(10):894-901.
[58]Yang J,Sun L,Wang L,et al.Activation of Sirt1/FXRsignaling pathway attenuates triptolide-induced hepatotoxicity in rats[J].Frontiers Pharmacol,2017,doi:org/10.3389/fphar.2017.00260.
[59]Wang J,Jiang Z,Ji J,et al.Gene expression profiling and pathway analysis of hepatotoxicity induced by triptolide in Wistar rats[J].Food Chem Toxicol,2013,58(3):495-505.
[60]Liang Q,Feng Q,Jia Z,et al.Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide[J].JEthnopharmacol,2015,170(5):28-38.
[61]王蓉,马腾茂,刘飞,等.防己的药理作用及临床应用研究进展[J].中国中药杂志,2017,42(4):634-639.
[62]张凯,王绪礼,王义坤,等.香科科属植物的化学成分和药理活性研究进展[J].中南药学,2016,14(7):735-741.
[63]蔡祯艳,易刚强,李云耀,等.筋骨草属植物中新克罗烷型二萜类成分的核磁共振谱图特征[J].中南药学,2014,12(11):1108-1112.
[64]曲桂武.安徽半枝莲中新克罗烷型二萜化合物的发现及抗肿瘤活性研究[D].青岛:中国海洋大学,2012.
[65]蒋竞,廖志新,吉民.克罗烷型二萜的结构与核磁共振特征[J].化工时刊,2007,21(12):49-53.
[66]刘继荣.黄药子引起中毒性肝炎2例[J].药物不良反应杂志,2002,4(2):129-130.
[67]梁琦,倪诚,颜贤忠,等.广防己、粉防己的肝肾毒性及代谢组学比较研究[J].中国中药杂志,2010,35(21):2882-2888.
[68]Lin D,Li C,Peng Y,et al.Cytochrome P450-mediated metabolic activation of diosbulbin B[J].Drug Metab Disp Biol Fate Chem,2014,42(10):1727.
[69]Li W,Lin D,Gao H,et al.Metabolic activation of furan moiety makes Diosbulbin B hepatotoxic[J].Archiv Toxicol,2016,90(4):863-872.
[70]曲晓宇,周利婷,张四喜,等.黄独素B致小鼠肝损伤过程中对肝外排型转运体Mrp2表达的影响[J].中国医院药学杂志,2016,36(19):1633-1636.
[71]Wang K,Lin D,Guo X,et al.Chemical identity of interaction of protein with reactive metabolite of diosbulbin B in vitro and in vivo[J].Toxins,2017,9(8):249.
[72]Hu Z,Zhou S,Zhang N,et al.Development of polyclonal antibodies for detection of diosbulbin B-derived cis-enedial protein adducts[J].Chem Res Toxicol,2018,254:64-69.
[73]牛成伟,陆宾,季莉莉,等.黄独素B诱导小鼠急性肝损伤及其机制[J].中国中药杂志,2014,39(7):1290-1292.
[74]Ma Y,Niu C,Wang J,et al.Diosbulbin B-induced liver injury in mice and its mechanism[J].Human Experim Toxicol,2014,33(7):729.
[75]马敏,江振洲,阮金兰,等.黄药子二萜内酯类成分对肝细胞毒性的实验研究[J].中国天然药物,2011,9(4):280-285.
[76]徐英,陈崇崇,杨莉,等.基于胆汁酸代谢网络分析中药黄药子的肝毒性[J].药学学报,2011,46(1):39-44.
[77]齐双岩,金若敏,刘红杰,等.川楝子致大鼠肝毒性机制研究[J].中国中药杂志,2008,33(16):2045-2047.
[78]Yu J,Deng P,Zhong D,et al.Identification of amino acid and glutathione N-conjugates of toosendanin:bioactivation of the furan ring mediated by CYP3A4[J].Chem Res Toxicol,2014,27(9):1598-1609.
[79]余京华,川楝素代谢活化和致肝毒性机制研究[D].北京:中国科学院大学,2015.
[80]张云海,川楝素肝脏毒性机理研究[D].上海:中国科学院上海药物研究所,2008.
[81]陆晓燕,郑洁,纪彩,等.基于毒理基因组学的川楝子肝毒性研究[A]//全国药物毒理学年会论文集[C].重庆:中国毒理学会,2016.
[82]孙蓉,吕丽莉,王丽,等.柴胡致大鼠肝毒性氧化损伤机制研究[J].中药药理与临床,2009,25(1):49-51.
[83]吕丽莉,黄伟,于晓,等.柴胡总皂苷粗提取物对大鼠肝毒性损伤作用研究[J].中国药物警戒,2009,6(4):202-206.
[84]黄伟,孙蓉,张作平.柴胡总皂苷粗提物多次给药对大鼠肝毒性的"量-时-毒"关系研究[J].中国中药杂志,2010,35(24):3344-3347.
[85]黄伟,吕丽莉,任海勇,等.柴胡总皂苷粗提物致大鼠肝毒性氧化损伤机制研究[J].中草药,2009,40(S1):227-229.
[86]李晓宇,李晓骄阳,孙蓉.柴胡皂苷a对人肝细胞L-02的体外肝毒性机制研究[A]//中国药学大会暨中国药师周论文集[C].南宁:中国药学会,2013.
[87]李涛,江振洲,王涛,等.柴胡皂苷d对人肝细胞L-O2体外毒性机制探讨[J].中国临床药理学与治疗学,2007,12(4):396-400.
[88]杨倩,李晓宇,赵新妹,等.含何首乌的中成药不良反应系统分析[J].中草药,2017,48(9):1878-1887.
[89]Jiang L L,Zhao D S,Fan Y X,et al.Detection of emodin derived glutathione adduct in normal rats administered with large dosage of Polygoni Multiflori Radix[J].Frontiers Pharmacol,2017,doi:org/10.3389/fphar.2017.00446.
[90]Qin B,Yang X,Chen J,et al.Chemical reactivity of emodin and its oxidative metabolites to thiols[J].Chem Res Toxicol,2016,29(12):2114-2124.
[91]Qin X,Peng Y,Zheng J.In vitro and in vivo studies of the ectrophilicity of physcion and its oxidative metabolites[J].Chem Res Toxicol,2018,doi:10.1021/acs.chemrestox.8b00026.
[92]Zhang T,Dong D,Lu D,et al.Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells[J].Int J Pharm,2016,501(1/2):190-198.
[93]汪美汐,王宇光,徐焕华,等.何首乌中大黄素对L02肝细胞CYP亚酶表达及细胞毒性的影响[J].中国药理学通报,2016,32(11):1543-1548.
[94]Tu C,Gao D,Li X F,et al.Inflammatory stress potentiates emodin-induced liver injury in rats[J].Frontiers Pharmacol,2015,6(233):233.
[95]马喆,赵珺睿,董冉冉,等.基于高内涵分析技术的何首乌提取物及其主要成分肝毒性研究[J].中草药,2016,47(22):4021-4029.
[96]Tu C,Gao D,Li X F,et al.Inflammatory stress potentiates emodin-induced liver injury in rats[J].Frontiers Pharmacol,2015,6(233):233.
[97]严建业,王元清,王炜,等.细辛中马兜铃酸A与黄樟醚的炮制减毒方法研究[J].中草药,2015,46(2):216-220.
[98]Yang A H,Zhang L,Zhi D X,et al.Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole[J].Xenobiotica,2017,48(11):1-23.
[99]Chiang S Y,Lee P Y,Lai M T,et al.Safrole-2′,3′-oxide induces cytotoxic and genotoxic effects in HepG2 cells and in mice[J].Mutation Res-Genetic Toxicol Envir Mutagen,2011,726(2):234-241.
[100]Liu T Y,Chen C C,Chen C L,et al.Safrole-induced oxidative damage in the liver of sprague-dawley rats[J].Food Chem Toxicol,1999,37(7):697-702.
[101]Chung Y T,Chen C L,Wu C C,et al.Safrole-DNAadduct in hepatocellular carcinoma associated with betel quid chewing[J].Toxicol Lett,2008,183(3):21-27.
[2]Yamashita Y I,Imai K,Mima K,et al.Idiosyncratic drug-induced liver injury:A short review[J].Hepatol Commun,2017,1(6):494-500.
[3]Clark J,Mcgoey L.The black box warning on philanthrocapitalism[J].Lancet,2016,388(10059):2457-2459.
[4]Cosyns B,Droogmans S.‘Black box warning’on food and drug administration criteria for drug-induced heart valve disease?[J].Eur Heart J Cardiov Imag,2015,16(2):154-155.
[5]Zeidan A M,Gore S D,Davidoff A J.US food and drug administration black box warning and its impact on the use of erythropoiesis-stimulating agents:Thinking outside the box[J].J Clin Oncol,2017,35(28):3264.
[6]孙润菲,孙明瑜.中草药诱导肝损伤的研究进展[J].中国医刊,2017,52(3):13-17.
[7]吴豪,钟荣玲,夏智,等.潜在肝毒性中药的成分研究进展[J].中国中药杂志,2016,41(17):3209-3217.
[8]雷怀成,易建华,刘涛.乌头碱中毒肝细胞凋亡的观察[J].毒理学杂志,2004,18(3):199-200.
[9]张开乔,卓荦,刘茜,等.乌头碱中毒的法医学研究进展[A]//证据理论与科学国际研讨会论文集[C].北京:中国政法大学2009.
[10]孙蓉,王晨.北豆根毒性研究进展[J].中国药物警戒,2009,6(9):546-549.
[11]曹思硕,杜军.吴茱萸毒理学研究进展[J].毒理学杂志,2017,31(5):396-400.
[12]张茜,周绮,金若敏,等.吴茱萸次碱对肝肾毒性的初步研究[J].中国实验方剂学杂志,2011,17(8):221-225.
[13]郭秋平,金若敏.苦参碱和氧化苦参碱致小鼠肝毒性比较[J].中国药理学与毒理学杂志,2016,30(7):736-740.
[14]Dreger M,Stanis?awska M,Krajewskapatan A,et al.Pyrrolizidine alkaloids-chemistry,biosynthesis,pathway,toxicity,safety and perspectives of medicinal usage[J].Herba Polonica,2009,55(4):127-147.
[15]Wiedenfeld H.Plants containing pyrrolizidine alkaloids:toxicity and problems[J].Food Add Contam,2011,28(3):282-292.
[16]Edgar J A,Colegate S M,Boppr?M,et al.Pyrrolizidine alkaloids in food:A spectrum of potential health consequences[J].Food Add Contam,2011,28(3):308-324.
[17]Merz K H,Schrenk D.Interim Relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines[J].Toxicol Lett,2016,doi:org/10.1016/j.toxlet.2916.05.002.
[18]Ruan J,Yang M,Fu P,et al.Metabolic activation of pyrrolizidine alkaloids:insights into the structural and enzymatic basis[J].Chem Res Toxicol,2014,27(6):1030-1039.
[19]Chen M,Li L,Zhong D,et al.9-Glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine is the major pyrrolic glutathione conjugate of retronecine-type pyrrolizidine alkaloids in liver microsomes and in rats[J].Chem Res Toxicol,2016,29(2):180-189.
[20]Wang C C,Xia Q,Li M,et al.Metabolic activation of pyrrolizidine alkaloids leading to phototoxicity and photogenotoxicity in human Ha Ca T keratinocytes[J].JEnvir Sci Health Part C Envir Carcinog Ecotoxicol Rev,2014,32(4):362-384.
[21]Merz K H,Schrenk D.Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines[J].Toxicol Lett,2016,263:44-57.
[22]Neuman M G,Cohen L,Opris M,et al.Hepatotoxicity of pyrrolizidine alkaloids[J].J Pharm Pharm Sci,2015,18(4):825-843.
[23]Yan X,Hong K,Feng J,et al.Identification of toxic pyrrolizidine alkaloids and their common hepatotoxicity mechanism[J].Int J Mol Sci,2016,17(3):318.
[24]Yang X,Li W,Sun Y,et al.A Comparative study of hepatotoxicity of pyrrolizidine alkaloids retrorsine and monocrotaline[J].Chem Res Toxicol,2017,30(2):532-539.
[25]Chen T,Mei N,Fu P P.Genotoxicity of pyrrolizidine alkaloids[J].J Appl Toxicol Jat,2010,30(3):183-196.
[26]Xia Q,Ma L,He X,et al.7-Glutathione pyrrole adduct-Apotential DNA reactive metabolite of pyrrolizidine alkaloids[J].Chem Res Toxicol,2015,28(4):615-620.
[27]Xia Q,Zhao Y,Tungeln L S V,et al.Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity[J].Chem Res Toxicol,2013,26(9):1384-1396.
[28]Tu M,Li L,Lei H,et al.Involvement of organic cation transporter 1 and CYP3A4 in retrorsine-induced toxicity[J].Toxicology,2014,322(4):34-42.
[29]Tu M,Sun S,Wang K,et al.Organic cation transporter 1mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity[J].Toxicology,2013,311(3):225-230.
[30]Naumann C,Hartmann T,Ober D.Evolutionary recruitment of a flavin-dependent monooxygenase for the detoxification of host plant-acquired pyrrolizidine alkaloids in the alkaloid-defended arctiid moth Tyria jacobaeae[J].Proceed Nat Acad Sci USA,2002,99(9):6085-6090.
[31]Yang M,Ruan J,Fu P P,et al.Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells:Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity[J].Chemico-Biol Interact,2016,243:119-126.
[32]Gao H,Ruan J Q,Chen J,et al.Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome[J].Drug Design Dev Therapy,2015,9:4861-4868.
[33]Ruan J,Gao H,Li N,et al.Blood pyrrole-protein adducts-A biomarker of pyrrolizidine alkaloid-induced liver injury in humans[J].J Envir Sci Health Part CEnvir Carcinog Ecotoxicol Rev,2015,33(4):404-421.
[34]Gao H,Li N,Wang J Y,et al.Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids[J].J Digestive Diseases,2012,13(1):33-39.
[35]姚军,戚新明,任进.野百合碱毒性机制研究进展[J].毒理学杂志,2014,doi:10.16421/j.cnki.1002-3127.
[36]Edgar J A,Molyneux R J,Colegate S M.Pyrrolizidine alkaloids:Potential role in the etiology of cancers,pulmonary hypertension,congenital anomalies,and liver disease[J].Chem Res Toxicol,2014,28(1):4-20.
[37]Hanumegowda U M,Copple B L,Shibuya M,et al.Basement membrane and matrix metalloproteinases in monocrotaline-induced liver injury[J].Toxicol Sci,2003,76(1):237-246.
[38]Luckert C,Hessel S,Lenze D,et al.Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids:A whole genome transcriptome analysis[J].Toxicology In Vitro,2015,29(7):1669-1682.
[39]Xiong A,Yang F,Fang L,et al.Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine,a hepatotoxic pyrrolizidine alkaloid[J].Chem Res Toxicol,2014,27(8):775-786.
[40]骆永伟,施畅,原野,等.雷公藤甲素的毒理学研究进展[J].毒理学杂志,2009,23(1):74-77.
[41]Liu J,Li L,Zhou X,et al.Metabolite profiling and identification of triptolide in rats[J].J Chromatogr BAnalyt Technol Biomed Life Sci,2013,939(22):51-58.
[42]Peng Z H,Wang J J,Du P,et al.Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography-tandem mass spectrometry[J].J Pharm Biomed Anal,2012,70(11):624-630.
[43]Du F,Liu T,Liu T,et al.Metabolite identification of triptolide by data-dependent accurate mass spectrometric analysis in combination with online hydrogen/deuterium exchange and multiple data-mining techniques[J].Rapid Commun Mass Spectrom,2011,25(20):3167-3177.
[44]Du F,Liu Z,Li X,et al.Metabolic pathways leading to detoxification of triptolide,a major active component of the herbal medicine Tripterygium wilfordii[J].J Appl Toxicol,2014,34(8):878-884.
[45]Zhuang X M,Shen G L,Xiao W B,et al.Assessment of the roles of P-glycoprotein and cytochrome P450 in triptolide-induced liver toxicity in sandwich-cultured rat hepatocyte model[J].Drug Metab Disp,2013,41(12):2158-2165.
[46]Lu Y,Xie T,Zhang Y,et al.Triptolide induces hepatotoxicity via inhibition of CYP450s in rat liver microsomes[J].Bmc Compl Altern Med,2017,17(1):15.
[47]姚金成,饶健,曾令贵,等.雷公藤甲素单次及多次给药对大鼠肝药酶活性的影响[J].中国药房,2010,21(11):961-964.
[48]Shen G,Zhuang X,Xiao W,et al.Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes[J].Food Chem Toxicol,2014,71(8):90-96.
[49]周利婷,曲晓宇,陶娌娜,等.雷公藤甲素致小鼠肝损伤对转运体Mrp2和Oatp2的影响[J].中国医院药学杂志,2016,36(21):1844-1847.
[50]姚金成,刘颖,胡领,等.雷公藤甲素对Caspase诱导人肝细胞L-02凋亡机制的研究[J].中国药房,2012,23(43):4036-4038.
[51]周静,张磊,吴瑕,等.雷公藤甲素对L-O2细胞凋亡及Caspase-3、ATPase、MMP、Ca2+的影响[J].中药药理与临床,2016,32(6):72-75.
[52]姚金成,刘颖,胡领,等.雷公藤甲素对人肝细胞L-02钙离子及P38MAPK磷酸化的影响[J].中国医院药学杂志,2013,33(10):760-763.
[53]刘泽洲,许可嘉,张天娇,等.雷公藤甲素诱导小鼠急性肝损伤的形态学研究[J].现代生物医学进展,2015,15(17):3207-3211.
[54]于淑静,魏彩冰,陶崑,等.雷公藤甲素致小鼠肝损伤的机制研究[J].天然产物研究与开发,2017,29(3):472-476.
[55]Wang X,Jiang Z,Xing M,et al.Interleukin-17 mediates triptolide-induced liver injury in mice[J].Food Chem Toxicol,2014,71(8):33-41.
[56]Wang X,Jiang Z,Cao W,et al.Th17/Treg imbalance in triptolide-induced liver injury[J].Fitoterapia,2014,93(3):245-251.
[57]Jing J,Xiaozhe S,Zhongxiang Z,et al.Activation of the farnesoid X receptor attenuates triptolide-induced liver toxicity[J].Phytomed Int J Phytotherapy Phytopharmacol,2015,22(10):894-901.
[58]Yang J,Sun L,Wang L,et al.Activation of Sirt1/FXRsignaling pathway attenuates triptolide-induced hepatotoxicity in rats[J].Frontiers Pharmacol,2017,doi:org/10.3389/fphar.2017.00260.
[59]Wang J,Jiang Z,Ji J,et al.Gene expression profiling and pathway analysis of hepatotoxicity induced by triptolide in Wistar rats[J].Food Chem Toxicol,2013,58(3):495-505.
[60]Liang Q,Feng Q,Jia Z,et al.Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide[J].JEthnopharmacol,2015,170(5):28-38.
[61]王蓉,马腾茂,刘飞,等.防己的药理作用及临床应用研究进展[J].中国中药杂志,2017,42(4):634-639.
[62]张凯,王绪礼,王义坤,等.香科科属植物的化学成分和药理活性研究进展[J].中南药学,2016,14(7):735-741.
[63]蔡祯艳,易刚强,李云耀,等.筋骨草属植物中新克罗烷型二萜类成分的核磁共振谱图特征[J].中南药学,2014,12(11):1108-1112.
[64]曲桂武.安徽半枝莲中新克罗烷型二萜化合物的发现及抗肿瘤活性研究[D].青岛:中国海洋大学,2012.
[65]蒋竞,廖志新,吉民.克罗烷型二萜的结构与核磁共振特征[J].化工时刊,2007,21(12):49-53.
[66]刘继荣.黄药子引起中毒性肝炎2例[J].药物不良反应杂志,2002,4(2):129-130.
[67]梁琦,倪诚,颜贤忠,等.广防己、粉防己的肝肾毒性及代谢组学比较研究[J].中国中药杂志,2010,35(21):2882-2888.
[68]Lin D,Li C,Peng Y,et al.Cytochrome P450-mediated metabolic activation of diosbulbin B[J].Drug Metab Disp Biol Fate Chem,2014,42(10):1727.
[69]Li W,Lin D,Gao H,et al.Metabolic activation of furan moiety makes Diosbulbin B hepatotoxic[J].Archiv Toxicol,2016,90(4):863-872.
[70]曲晓宇,周利婷,张四喜,等.黄独素B致小鼠肝损伤过程中对肝外排型转运体Mrp2表达的影响[J].中国医院药学杂志,2016,36(19):1633-1636.
[71]Wang K,Lin D,Guo X,et al.Chemical identity of interaction of protein with reactive metabolite of diosbulbin B in vitro and in vivo[J].Toxins,2017,9(8):249.
[72]Hu Z,Zhou S,Zhang N,et al.Development of polyclonal antibodies for detection of diosbulbin B-derived cis-enedial protein adducts[J].Chem Res Toxicol,2018,254:64-69.
[73]牛成伟,陆宾,季莉莉,等.黄独素B诱导小鼠急性肝损伤及其机制[J].中国中药杂志,2014,39(7):1290-1292.
[74]Ma Y,Niu C,Wang J,et al.Diosbulbin B-induced liver injury in mice and its mechanism[J].Human Experim Toxicol,2014,33(7):729.
[75]马敏,江振洲,阮金兰,等.黄药子二萜内酯类成分对肝细胞毒性的实验研究[J].中国天然药物,2011,9(4):280-285.
[76]徐英,陈崇崇,杨莉,等.基于胆汁酸代谢网络分析中药黄药子的肝毒性[J].药学学报,2011,46(1):39-44.
[77]齐双岩,金若敏,刘红杰,等.川楝子致大鼠肝毒性机制研究[J].中国中药杂志,2008,33(16):2045-2047.
[78]Yu J,Deng P,Zhong D,et al.Identification of amino acid and glutathione N-conjugates of toosendanin:bioactivation of the furan ring mediated by CYP3A4[J].Chem Res Toxicol,2014,27(9):1598-1609.
[79]余京华,川楝素代谢活化和致肝毒性机制研究[D].北京:中国科学院大学,2015.
[80]张云海,川楝素肝脏毒性机理研究[D].上海:中国科学院上海药物研究所,2008.
[81]陆晓燕,郑洁,纪彩,等.基于毒理基因组学的川楝子肝毒性研究[A]//全国药物毒理学年会论文集[C].重庆:中国毒理学会,2016.
[82]孙蓉,吕丽莉,王丽,等.柴胡致大鼠肝毒性氧化损伤机制研究[J].中药药理与临床,2009,25(1):49-51.
[83]吕丽莉,黄伟,于晓,等.柴胡总皂苷粗提取物对大鼠肝毒性损伤作用研究[J].中国药物警戒,2009,6(4):202-206.
[84]黄伟,孙蓉,张作平.柴胡总皂苷粗提物多次给药对大鼠肝毒性的"量-时-毒"关系研究[J].中国中药杂志,2010,35(24):3344-3347.
[85]黄伟,吕丽莉,任海勇,等.柴胡总皂苷粗提物致大鼠肝毒性氧化损伤机制研究[J].中草药,2009,40(S1):227-229.
[86]李晓宇,李晓骄阳,孙蓉.柴胡皂苷a对人肝细胞L-02的体外肝毒性机制研究[A]//中国药学大会暨中国药师周论文集[C].南宁:中国药学会,2013.
[87]李涛,江振洲,王涛,等.柴胡皂苷d对人肝细胞L-O2体外毒性机制探讨[J].中国临床药理学与治疗学,2007,12(4):396-400.
[88]杨倩,李晓宇,赵新妹,等.含何首乌的中成药不良反应系统分析[J].中草药,2017,48(9):1878-1887.
[89]Jiang L L,Zhao D S,Fan Y X,et al.Detection of emodin derived glutathione adduct in normal rats administered with large dosage of Polygoni Multiflori Radix[J].Frontiers Pharmacol,2017,doi:org/10.3389/fphar.2017.00446.
[90]Qin B,Yang X,Chen J,et al.Chemical reactivity of emodin and its oxidative metabolites to thiols[J].Chem Res Toxicol,2016,29(12):2114-2124.
[91]Qin X,Peng Y,Zheng J.In vitro and in vivo studies of the ectrophilicity of physcion and its oxidative metabolites[J].Chem Res Toxicol,2018,doi:10.1021/acs.chemrestox.8b00026.
[92]Zhang T,Dong D,Lu D,et al.Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells[J].Int J Pharm,2016,501(1/2):190-198.
[93]汪美汐,王宇光,徐焕华,等.何首乌中大黄素对L02肝细胞CYP亚酶表达及细胞毒性的影响[J].中国药理学通报,2016,32(11):1543-1548.
[94]Tu C,Gao D,Li X F,et al.Inflammatory stress potentiates emodin-induced liver injury in rats[J].Frontiers Pharmacol,2015,6(233):233.
[95]马喆,赵珺睿,董冉冉,等.基于高内涵分析技术的何首乌提取物及其主要成分肝毒性研究[J].中草药,2016,47(22):4021-4029.
[96]Tu C,Gao D,Li X F,et al.Inflammatory stress potentiates emodin-induced liver injury in rats[J].Frontiers Pharmacol,2015,6(233):233.
[97]严建业,王元清,王炜,等.细辛中马兜铃酸A与黄樟醚的炮制减毒方法研究[J].中草药,2015,46(2):216-220.
[98]Yang A H,Zhang L,Zhi D X,et al.Identification and analysis of the reactive metabolites related to the hepatotoxicity of safrole[J].Xenobiotica,2017,48(11):1-23.
[99]Chiang S Y,Lee P Y,Lai M T,et al.Safrole-2′,3′-oxide induces cytotoxic and genotoxic effects in HepG2 cells and in mice[J].Mutation Res-Genetic Toxicol Envir Mutagen,2011,726(2):234-241.
[100]Liu T Y,Chen C C,Chen C L,et al.Safrole-induced oxidative damage in the liver of sprague-dawley rats[J].Food Chem Toxicol,1999,37(7):697-702.
[101]Chung Y T,Chen C L,Wu C C,et al.Safrole-DNAadduct in hepatocellular carcinoma associated with betel quid chewing[J].Toxicol Lett,2008,183(3):21-27.